Description

DHCMT (4-Chlorodehydromethyltestosterone), commonly known as Turinabol, is a unique oral anabolic steroid that is a hybrid of Dianabol (Methandrostenolone) and Clostebol. This modification results in a compound with distinct characteristics, offering moderate anabolic effects with very low androgenic and estrogenic activity. DHCMT is known for promoting steady, quality lean muscle gains with minimal water retention.

Mechanism of Action

The mechanism of action for DHCMT involves its binding to androgen receptors to stimulate protein synthesis and nitrogen retention. Its structural modifications—specifically the addition of a chlorine atom at the 4th position and the removal of the carbon 1-2 double bond—dramatically reduce its affinity for aromatase and the 5-alpha reductase enzyme. This means DHCMT does not convert to estrogen and has a very low rate of conversion to a more potent DHT derivative. The result is a compound that provides clean, dry gains without the risk of estrogenic side effects or pronounced androgenic effects.

Clinical Application and Dosage

DHCMT has a historical association with state-sponsored athletic performance programs but has no current approved medical use. In modern performance contexts, DHCMT is used during cutting phases or lean bulk cycles where the goal is to add solid muscle tissue without bloating, making it popular for both athletic performance and physique conditioning.

Dosage of DHCMT is typically moderate due to its mild nature and hepatotoxicity from 17-alpha-alkylation. For men, common daily dosages range from 25 mg to 75 mg, often split into two doses. The 25 mg tablet strength of this DHCMT formulation allows for convenient dosing, where one tablet provides a solid baseline dose. For women, doses are much lower, typically 5 mg to 10 mg daily. Cycles are usually limited to 6-8 weeks to manage liver strain.

Treatment Protocol and Monitoring

A cycle with oral DHCMT is typically run for 6-8 weeks. Its effects are steady and cumulative rather than dramatic, with increases in strength and lean mass becoming apparent over several weeks. Responsible use of DHCMT requires health monitoring, including blood tests to check liver enzymes (AST/ALT) and lipid profiles, as it can negatively impact cholesterol by suppressing HDL. Blood pressure should also be monitored, though hypertension is less common than with aromatizing compounds.

Pharmacological Profile

DHCMT is a 17-alpha-alkylated anabolic steroid, which allows for oral administration but confers hepatotoxicity. It has a half-life of approximately 16 hours, supporting once or twice-daily dosing. It is not aromatizable and has very low androgenic activity. DHCMT is metabolized in the liver and excreted in urine.

Common Side Effects

While considered one of the milder oral steroids, DHCMT is not without side effects, primarily related to its hepatotoxicity and impact on cholesterol. The most common include:

• Hepatotoxicity: Causes stress on the liver, with elevated liver enzymes expected during use.
• Negative Lipid Impact: Can suppress HDL (“good”) cholesterol and potentially elevate LDL.
• Suppression of Natural Testosterone: Significant inhibition of the HPTA, requiring a testosterone base and post-cycle therapy.
• Low Androgenic Effects: Potential for mild androgenic sides like acne or hair loss is low but possible in very sensitive individuals.
• Low Estrogenic Effects: No water retention or gynecomastia due to non-aromatization, though some users report joint dryness.

DHCMT is often praised for its lack of estrogenic side effects and mild nature. It is contraindicated for individuals with pre-existing liver or cardiovascular disease.

You can buy DHCMT (Turinabol) made by Apoxar in bulk in Canada via our website. Navigate to the “Purchase” tab and fill the contact form with details of your wholesale order. Please note: we do not sell single packs or ship directly to consumers, Apoxar is a wholesale fitness medication manufacturer and we work exclusively with our approved distributors.